SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SNRS- Sunrise Technologies
SNRS 0.0000010000.0%Jun 6 11:01 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mike Baker who wrote (1662)9/30/1998 8:41:00 AM
From: majormember  Read Replies (1) of 4140
 
Mike,

You seem to have good knowledge of SNRS. All I can add is
BEAM and VISX were the first two co's to get FDA approval
for their excimers, and their market values afterwards reached
1 billion (BEAM) and $600 million (VISX).

SNRS, IMO, has a larger potential as it targets a larger market, potential is 2 billion, has excellent management and at $5 per
share, has incredible profit vs. loss potential.

To get current analysis, you should call Penn Merchant.

Regards,
Skane
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext